SLC30A8 and type 2 diabetes mellitus: It remains to be defined to what extent a decreased rate of cell death (and thus a suggested preserved mass of insulin-secreting cells with proper function) contributes to a protective effect of ZnT8 loss-of-function in the context of T2DM.